Clinical Trial: Parecoxib in Renal Colic

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Multicenter Single-Blind, Single Dose Efficacy and Safety Pilot Study Comparing Intramuscular Parecoxib and Diclofenac in Renal Colic

Brief Summary: This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pain due to renal colic.

Detailed Summary: August 29, 2005
Sponsor: Pfizer

Current Primary Outcome: Evaluation of efficacy through: time to onset of pain relief and time to remedication.

Original Primary Outcome: Same as current

Current Secondary Outcome: Evaluation of efficacy through: Pain Intensity (VAS), Pain Relief (PR) and several measurements of analgesia that will be derived from VAS and PR Physician's Global Evaluation at 12 hours Patient's Global Evaluation at 12 hours

Original Secondary Outcome: Same as current

Information By: Pfizer

Dates:
Date Received: August 29, 2005
Date Started: April 2002
Date Completion: April 2004
Last Updated: May 2, 2008
Last Verified: May 2008